跳至主要内容
临床试验/IRCT2016121228173N3
IRCT2016121228173N3已完成未知

Clinical trial Comparison of the effect of Aripiprazole and placebo on the rate of smoking in male patients with type I bipolar disorder

Vice chancellor for research, Tabriz University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 60 years(—)
性别
Male

入选标准

  • Inclusion Criteria: The definitive diagnosis of bipolar I disorder according to DSM-IV-TR criteria; being in the partial or complete recovery phase based on Yang Mania Rating Scale; having the necessary criteria for diagnosis of nicotine dependence according to DSM-IV-TR criteria; age 18-60 Years old; male gender and consent to attend the study through the signing of informed consent.

排除标准

  • history of any allergic reaction to drug disorder with respect to Aripiprazole or other anti psychotics; dependence on other substances (based on the patient's history and the outcome of the test of morphine and methamphetamine at the start of the intervention); the use of other drugs used to quit nicotine; Use of medications other than bipolar disorder; history of physical illness (liver failure, renal failure); history of mental retardation; occurrence of any side effects due to Aripiprazole; history of cognitive impairment (dementia).

研究者

发起方
Vice chancellor for research, Tabriz University of Medical Sciences

相似试验

Effect of Aripiprazole on Smoking Rate in Male... | 临床试验